Full data view for gene PRPF31

This database is one of the "Eye disease" gene variant databases.
Information The variants shown are described using the NM_015629.3 transcript reference sequence.

8 entries on 1 page. Showing entries 1 - 8.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+?/. _1_ c.? r.spl p.(?) Both (homozygous) - likely pathogenic g.68679654G>A g.68645751G>A c.160+1G>A - PRPF31_000214 Heterozygous deletion in PRPF31 exon 1 and 5′ (putative promoter) regi PubMed: Shakhmantsir 2020 - - Germline ? - - - - DNA ? - cell line experiment retinal disease JB878 (RP2) PubMed: Shakhmantsir 2020 - M - Brazil - - - - - 1 LOVD
+?/. - c.? r.0? p.0? Unknown - likely pathogenic g.54622548_54633842del - chr19:g.54622548_54633842del - PRPF31_000214 heterozygous PubMed: Turro 2020 - - Germline/De novo (untested) ? - - - - DNA SEQ-NG-I blood whole genome sequencing retinal disease G001008 PubMed: Turro 2020 only individuals with mutations in retinal disease genes from this publication were inserted into LOVD ? - (United Kingdom (Great Britain)) - - - - - 1 LOVD
+?/. - c.? r.0? p.0? Unknown - likely pathogenic g.54632279_54632481del - chr19:g.54632279_54632481del - PRPF31_000214 heterozygous PubMed: Turro 2020 - - Germline/De novo (untested) ? - - - - DNA SEQ-NG-I blood whole genome sequencing retinal disease G006015 PubMed: Turro 2020 only individuals with mutations in retinal disease genes from this publication were inserted into LOVD ? - (United Kingdom (Great Britain)) - - - - - 1 LOVD
+/. _1_14_ c.? r.(?) p.? Unknown ACMG pathogenic g.54619709_54635793del g.54116329_54132413del PRPF31 g.54619709-54635793del, p.? - PRPF31_000214 heterozygous PubMed: Wang 2022 - - Germline/De novo (untested) ? - - - - DNA SEQ-NG, SEQ blood exome sequencing retinal disease 22043_I:2 PubMed: Wang 2022 family 22043, individual I:2; 3-generation family, 3 affected F - China Chinese - - - - 1 LOVD
+/. _1_14_ c.? r.(?) p.? Maternal (confirmed) ACMG pathogenic g.54619709_54635793del g.54116329_54132413del PRPF31 g.54619709-54635793del, p.? - PRPF31_000214 heterozygous PubMed: Wang 2022 - - Germline yes - - - - DNA SEQ-NG, SEQ blood exome sequencing retinal disease 22043_II:2 PubMed: Wang 2022 family 22043, individual II:2; 3-generation family, 3 affected F - China Chinese - - - - 1 LOVD
+/. _1_14_ c.? r.(?) p.? Maternal (confirmed) ACMG pathogenic g.54619709_54635793del g.54116329_54132413del PRPF31 g.54619709-54635793del, p.? - PRPF31_000214 heterozygous PubMed: Wang 2022 - - Germline yes - - - - DNA SEQ-NG, SEQ blood exome sequencing retinal disease 22043_III:1 PubMed: Wang 2022 family 22043, individual III:1; 3-generation family, 3 affected F - China Chinese - - - - 1 LOVD
+?/. - c.663_665delCAT r.(?) p.(Ile2223del) Both (homozygous) - likely pathogenic g.68679654G>A g.68645751G>A c.160+1G>A - PRPF31_000214 - PubMed: Shakhmantsir 2020 - - Germline yes - - - - DNA ? - cell line experiment retinal disease JB774 (RP1) PubMed: Shakhmantsir 2020 father of JB773 M - Brazil - - - - - 1 LOVD
+?/. - c.663_665delCAT r.(?) p.(Ile2223del) Both (homozygous) - likely pathogenic g.68679654G>A g.68645751G>A c.160+1G>A - PRPF31_000214 - PubMed: Shakhmantsir 2020 - - Germline yes - - - - DNA ? - cell line experiment retinal disease JB773 (RP3) PubMed: Shakhmantsir 2020 son of JB774 M - Brazil - - - - - 1 LOVD
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.